Therapeutic efficacy and tolerability of artemether–lumefantrine for uncomplicated Plasmodium falciparum malaria in Niger, 2020

Therapeutic efficacy and tolerability of artemether–lumefantrine for uncomplicated Plasmodium falciparum malaria in Niger, 2020

Abstract Background Monitoring therapeutic efficacy is important to ensure the efficacy of artemisinin-based combination therapy (ACT) for malaria. The current first-line treatment for uncomplicated malaria recommended by the National Malaria Control Program in Niger is artemether–lumefantrine (AL)....

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Ibrahim M. Laminou, Ibrahima Issa, Eric Adehossi, Kabirou Maman, Hadiza Jackou, Eric Coulibaly, Zilahatou B. Tohon, Jehan Ahmed, Elisha Sanoussi, Daniel Koko
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: BMC 2024-05-01
Loạt:Malaria Journal
Những chủ đề:
Resistance
P. falciparum
Artemether–lumefantrine
Efficacy
Niger
Truy cập trực tuyến:https://doi.org/10.1186/s12936-024-04945-8

Internet

https://doi.org/10.1186/s12936-024-04945-8

Những quyển sách tương tự